drugset / Trial / NCT00143169

Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain

NCT00143169

Phase 3 Completed 220 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To validate the morphine-sparing effect and safety of parecoxib administered intravenously for the treatment of Chinese subjects with postoperative pain following gynecological or orthopedic surgery.

Timeline

Start
2004-09
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule Intravenous

Indications

No indication recorded.